JP2019525897A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019525897A5 JP2019525897A5 JP2018563925A JP2018563925A JP2019525897A5 JP 2019525897 A5 JP2019525897 A5 JP 2019525897A5 JP 2018563925 A JP2018563925 A JP 2018563925A JP 2018563925 A JP2018563925 A JP 2018563925A JP 2019525897 A5 JP2019525897 A5 JP 2019525897A5
- Authority
- JP
- Japan
- Prior art keywords
- immunoglobulin
- residue
- amino acid
- item
- binding portion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662348410P | 2016-06-10 | 2016-06-10 | |
| US62/348,410 | 2016-06-10 | ||
| PCT/JP2017/021672 WO2017213267A1 (en) | 2016-06-10 | 2017-06-12 | Lysine conjugated immunoglobulins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019525897A JP2019525897A (ja) | 2019-09-12 |
| JP2019525897A5 true JP2019525897A5 (https=) | 2020-07-16 |
| JP7041077B2 JP7041077B2 (ja) | 2022-03-23 |
Family
ID=59315675
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018563925A Active JP7041077B2 (ja) | 2016-06-10 | 2017-06-12 | リジン結合体化免疫グロブリン |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US10941431B2 (https=) |
| EP (1) | EP3468614A1 (https=) |
| JP (1) | JP7041077B2 (https=) |
| KR (1) | KR102538866B1 (https=) |
| CN (1) | CN109475642B (https=) |
| AU (1) | AU2017279352B2 (https=) |
| BR (1) | BR112018075253A2 (https=) |
| CA (1) | CA3026991A1 (https=) |
| CL (1) | CL2021003383A1 (https=) |
| CO (1) | CO2018013314A2 (https=) |
| IL (1) | IL263329B (https=) |
| JO (1) | JOP20180118A1 (https=) |
| MX (1) | MX419566B (https=) |
| MY (1) | MY202858A (https=) |
| NZ (1) | NZ748605A (https=) |
| PE (1) | PE20190340A1 (https=) |
| PH (1) | PH12018502594A1 (https=) |
| RU (2) | RU2021136863A (https=) |
| SG (1) | SG11201810470XA (https=) |
| UA (1) | UA126799C2 (https=) |
| WO (1) | WO2017213267A1 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA124622C2 (uk) | 2015-12-18 | 2021-10-20 | ЕЙСАЙ Ар ЕНД Ді МЕНЕДЖМЕНТ КО., ЛТД. | Кон'юговані імуноглобуліни з c-кінцевим лізином |
| MY202858A (en) | 2016-06-10 | 2024-05-25 | Eisai R&D Man Co Ltd | Lysine conjugated immunoglobulins |
| AU2020268684C1 (en) * | 2019-05-09 | 2026-04-02 | Merus B.V. | Variant domains for multimerizing proteins and separation thereof |
| GB201907093D0 (en) * | 2019-05-20 | 2019-07-03 | Ucl Business Plc | Antibody functionalisation |
| CN115335406B (zh) * | 2020-02-12 | 2026-01-30 | 伊莱利利公司 | 抗体或抗原-结合片段的结晶 |
| BR112022018452A2 (pt) * | 2020-03-25 | 2022-11-01 | Lilly Co Eli | Proteínas de ligação multiespecíficas e métodos de desenvolvimento das mesmas |
| JP7787101B2 (ja) | 2020-05-20 | 2025-12-16 | ヤンセン バイオテツク，インコーポレーテツド | グリコシル化Ｆｃドメインを含むタンパク質の部位特異的コンジュゲーションのための方法 |
| AU2021350011A1 (en) * | 2020-09-25 | 2023-05-11 | Epivax, Inc. | Retro-inverso regulatory t cell epitopes |
| AU2022333321A1 (en) * | 2021-08-27 | 2024-04-11 | Janssen Biotech, Inc. | Anti-psma antibodies and uses thereof |
| CN117164701A (zh) * | 2022-12-27 | 2023-12-05 | 优洛生物(上海)有限公司 | 一种经改造的抗体、其制备方法及其用途 |
| CN120813607A (zh) | 2023-02-28 | 2025-10-17 | 卫材R&D管理有限公司 | 抗psma抗体、缀合物和使用方法 |
| WO2024211135A2 (en) * | 2023-04-07 | 2024-10-10 | Regeneron Pharmaceuticals, Inc. | Characterization of crosslinking sites in antibody-drug conjugates |
| CN119375471A (zh) * | 2023-07-26 | 2025-01-28 | 菲鹏生物股份有限公司 | 抗体和抗体缀合物及其用途 |
| TW202602943A (zh) | 2024-03-22 | 2026-01-16 | 日商衛材R&D企管股份有限公司 | 抗ｔｒｏｐ２抗體藥物偶聯物及使用方法 |
| CN120779021A (zh) * | 2024-04-08 | 2025-10-14 | 菲鹏生物股份有限公司 | 抗体缀合物及其用途 |
| WO2026044039A2 (en) | 2024-08-21 | 2026-02-26 | Eisai R&D Management Co., Ltd. | Anti-cd73 antibodies, conjugates, and methods of use |
| WO2026044149A2 (en) | 2024-08-21 | 2026-02-26 | Eisai R&D Management Co., Ltd. | Synthesis of drug-linker combinations for antibody-drug conjugates |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0368684B2 (en) | 1988-11-11 | 2004-09-29 | Medical Research Council | Cloning immunoglobulin variable domain sequences. |
| ES2642214T3 (es) | 2004-01-21 | 2017-11-15 | Novo Nordisk Health Care Ag | Conjugación de péptidos mediante transglutaminasa |
| CA2813411C (en) * | 2010-11-05 | 2016-08-02 | Rinat Neuroscience Corporation | Engineered polypeptide conjugates and methods for making thereof using transglutaminase |
| WO2013176516A1 (ko) | 2012-05-24 | 2013-11-28 | 한화케미칼 주식회사 | 트랜스글루타미나아제를 이용하여 제조한 항체-약물 결합체 및 이의 용도 |
| EP3564259A3 (en) * | 2012-11-09 | 2020-02-12 | Innate Pharma | Recognition tags for tgase-mediated conjugation |
| WO2014159579A1 (en) | 2013-03-14 | 2014-10-02 | Abbvie Inc. | MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE |
| CN105517577A (zh) * | 2013-06-21 | 2016-04-20 | 先天制药公司 | 多肽的酶促偶联 |
| AU2014286990A1 (en) * | 2013-07-11 | 2016-02-11 | Novartis Ag | Lysine-specific chemoenzymatic protein modifications using microbial transglutaminase |
| WO2015015448A2 (en) * | 2013-07-31 | 2015-02-05 | Rinat Neuroscience Corp. | Engineered polypeptide conjugates |
| PT3134127T (pt) * | 2014-04-25 | 2020-04-09 | Rinat Neuroscience Corp | Conjugados de anticorpo-fármaco com alta carga de fármaco |
| UA124622C2 (uk) * | 2015-12-18 | 2021-10-20 | ЕЙСАЙ Ар ЕНД Ді МЕНЕДЖМЕНТ КО., ЛТД. | Кон'юговані імуноглобуліни з c-кінцевим лізином |
| MY202858A (en) | 2016-06-10 | 2024-05-25 | Eisai R&D Man Co Ltd | Lysine conjugated immunoglobulins |
-
2017
- 2017-06-12 MY MYPI2018002415A patent/MY202858A/en unknown
- 2017-06-12 PE PE2018003193A patent/PE20190340A1/es unknown
- 2017-06-12 AU AU2017279352A patent/AU2017279352B2/en active Active
- 2017-06-12 BR BR112018075253-3A patent/BR112018075253A2/pt unknown
- 2017-06-12 RU RU2021136863A patent/RU2021136863A/ru unknown
- 2017-06-12 MX MX2018015331A patent/MX419566B/es unknown
- 2017-06-12 CA CA3026991A patent/CA3026991A1/en active Pending
- 2017-06-12 UA UAA201900242A patent/UA126799C2/uk unknown
- 2017-06-12 SG SG11201810470XA patent/SG11201810470XA/en unknown
- 2017-06-12 NZ NZ748605A patent/NZ748605A/en unknown
- 2017-06-12 KR KR1020197000701A patent/KR102538866B1/ko active Active
- 2017-06-12 JP JP2018563925A patent/JP7041077B2/ja active Active
- 2017-06-12 EP EP17737890.8A patent/EP3468614A1/en active Pending
- 2017-06-12 WO PCT/JP2017/021672 patent/WO2017213267A1/en not_active Ceased
- 2017-06-12 CN CN201780043485.4A patent/CN109475642B/zh active Active
- 2017-06-12 RU RU2018145507A patent/RU2762939C2/ru active
- 2017-07-28 US US15/662,981 patent/US10941431B2/en active Active
-
2018
- 2018-11-27 IL IL263329A patent/IL263329B/en unknown
- 2018-12-07 CO CONC2018/0013314A patent/CO2018013314A2/es unknown
- 2018-12-09 JO JOP/2018/0118A patent/JOP20180118A1/ar unknown
- 2018-12-10 PH PH12018502594A patent/PH12018502594A1/en unknown
-
2021
- 2021-01-27 US US17/159,655 patent/US11753669B2/en active Active
- 2021-12-16 CL CL2021003383A patent/CL2021003383A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019525897A5 (https=) | ||
| JP2019502684A5 (https=) | ||
| JP7133611B2 (ja) | 高いインビボ忍容性を有するアントラサイクリン系の抗体薬物複合体 | |
| ES2277344T3 (es) | Purificacion de anticuerpos mediante cromatografia de interaccion hidrofobica a ph bajo. | |
| US20220088212A1 (en) | C-terminal lysine conjugated immunoglobulins | |
| ES2549077T3 (es) | Espectrometría de masas de conjugados de anticuerpos | |
| CN109475642B (zh) | 赖氨酸缀合的免疫球蛋白 | |
| JP6585600B2 (ja) | Ｃ末端軽鎖ポリペプチド伸長を含有する抗体、ならびにその複合体及びその使用方法 | |
| BR112015023589B1 (pt) | Método para a produção de um conjugado de imunoligante/carga útil | |
| JP7514836B2 (ja) | トランスグルタミナーゼによるコンジュゲーションのための改変抗体、ならびにそのコンジュゲート、方法および用途 | |
| JP2018520092A5 (https=) | ||
| EP2635310A2 (en) | Engineered polypeptide conjugates and methods for making thereof using transglutaminase | |
| JP7339291B2 (ja) | シクロホスファミド及びイホスファミドのイムノアッセイ用の免疫原及びアッセイ接合体として用いるシクロホスファミド類似体 | |
| CN110799537A (zh) | 抗pd-1抗体及其制备和使用方法 | |
| EP3999544A1 (en) | Polypeptide complex for conjugation and use thereof | |
| JP2024545170A5 (https=) | ||
| AU2019386945B2 (en) | Antibody comprising a glutamine-containing light chain C-terminal extension, conjugates thereof, and methods and uses | |
| TWI591176B (zh) | 抗ｌｉｖ－１之人化抗體類及彼等於治療癌症上之用途 | |
| CA3008645C (en) | C-terminal lysine conjugated immunoglobulins | |
| KR20250045545A (ko) | 항체-킬레이터 콘쥬게이트 | |
| JP2024500921A (ja) | 開環チオスクシンイミド基、オリゴペプチドフラグメント及びキラル部分を含む新規異性化合物 | |
| NZ751907B2 (en) | Anti-muc16 (mucin 16) antibodies | |
| NZ751907A (en) | Anti-muc16 (mucin 16) antibodies | |
| BR112016018005B1 (pt) | Conjugados anticorpo-droga e imunotoxinas |